Delphia (USA)’s Vertex Pharmaceuticals VRTX Stock Holding History

Delphia (USA)’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$359K	Sell
2023 Q1	$470K	Buy
2022 Q4	$212K	Buy
2022 Q3	–	Sell
2022 Q2	$470K	Sell
2022 Q1	$542K	Buy
2021 Q4	$455K	Buy